title: Taspase1: a 'misunderstood' protease with translational cancer relevance.
abstract: Proteolysis is not only a critical requirement for life, but the executing enzymes also play important roles in numerous pathological conditions, including cancer. Therefore, targeting proteases is clearly relevant for improving cancer patient care. However, to effectively control proteases, a profound knowledge of their mechanistic function as well as their regulation and downstream signalling in health and disease is required. The highly conserved protease Threonine Aspartase1 (Taspase1) is overexpressed in numerous liquid and solid malignancies and was characterized as a 'non-oncogene addiction' protease. Although Taspase1 was shown to cleave various regulatory proteins in humans as well as leukaemia provoking mixed lineage leukaemia fusions, our knowledge on its detailed functions and the underlying mechanisms contributing to cancer is still incomplete. Despite superficial similarity to type 2 asparaginases as well as Ntn proteases, such as the proteasome, Taspase1-related research so far gives us the picture of a unique protease exhibiting special features. Moreover, neither effective genetic nor chemical inhibitors for this enzyme are available so far, thus hampering not only to further dissect Taspase1's pathobiological functions but also precluding the assessment of its clinical impact. Based on recent insights, we here critically review the current knowledge of Taspase1's structure-function relationship and its mechanistic relevance for tumorigenesis obtained from in vitro and in vivo cancer models. We provide a comprehensive overview of tumour entities for which Taspase1 might be of predictive and therapeutic value, and present the respective experimental evidence. To stimulate progress in the field, a comprehensive overview of Taspase1 targeting approaches is presented, including coverage of Taspase1-related patents. We conclude by discussing future inhibition strategies and relevant challenges, which need to be resolved by the field.
authors.affiliation: Molecular and Cellular Oncology, ENT/University Medical Center of Mainz, Mainz, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Wünsch
authors.affiliation: Molecular and Cellular Oncology, ENT/University Medical Center of Mainz, Mainz, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Hahlbrock
authors.affiliation: Institute for Pharmacy and Biochemistry, University of Mainz, Mainz, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Jung
authors.affiliation: Institute for Pharmacy and Biochemistry, University of Mainz, Mainz, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Schirmeister
authors.affiliation: Structural Biochemistry, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.
authors.forename: J
authors.initials: J
authors.lastname: van den Boom
authors.affiliation: Institute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.
authors.forename: O
authors.initials: O
authors.lastname: Schilling
authors.affiliation: Institute for Molecular Biology, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.
authors.forename: S K
authors.initials: SK
authors.lastname: Knauer
authors.affiliation: Molecular and Cellular Oncology, ENT/University Medical Center of Mainz, Mainz, Germany.
authors.forename: R H
authors.initials: RH
authors.lastname: Stauber
mesh_terms: D001220:Aspartate Ammonia-Lyase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D010450:Endopeptidases / Q000235:genetics / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000627:therapeutic use; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D015394:Molecular Structure; D009369:Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000517:prevention & control; D013912:Threonine / Q000378:metabolism*; D057170:Translational Research, Biomedical / Q000379:methods*
chemical_list: D004791:Enzyme Inhibitors; D013912:Threonine; D010450:Endopeptidases; C480823:taspase1, human; D001220:Aspartate Ammonia-Lyase